Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheila M Fleming

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Neuroscience Letters|February 6, 2010
Mice overexpressing corticotropin-releasing factor show brain atrophy and motor dysfunctionsMiriam Goebel, Sheila M Fleming, Mulugeta Million, et al.
Molecular Therapy. Methods & Clinical Development|April 17, 2023
iPSC-derived neural precursor cells engineering <i>GBA1</i> recovers acid β-glucosidase deficiency and diminishes α-synuclein and neuropathologyYanyan Peng, Benjamin Liou, Yi Lin, et al.
Trends in Neurosciences|October 12, 2004
Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfectMichael S Levine, Carlos Cepeda, Miriam A Hickey, et al.
Molecular Neurodegeneration|December 15, 2011
Analysis of striatal transcriptome in mice overexpressing human wild-type alpha-synuclein supports synaptic dysfunction and suggests mechanisms of neuroprotection for striatal neuronsYofre Cabeza-Arvelaiz, Sheila M Fleming, Franziska Richter, et al.
The European Journal of Neuroscience|August 16, 2008
Olfactory deficits in mice overexpressing human wildtype alpha-synucleinSheila M Fleming, Nicole A Tetreault, Caitlin K Mulligan, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 22, 2004
Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synucleinSheila M Fleming, Jonathan Salcedo, Pierre-Olivier Fernagut, et al.
Neuropathology and Applied Neurobiology|March 26, 2021
Irisin treatment lowers levels of phosphorylated tau in the hippocampus of pre-symptomatic female but not male htau miceKatie A Bretland, Li Lin, Kimberly M Bretland, et al.
Behavioural Brain Research|February 7, 2018
Exacerbation of sensorimotor dysfunction in mice deficient in Atp13a2 and overexpressing human wildtype alpha-synucleinEmily R Dirr, Osunde R Ekhator, Rachel Blackwood, et al.
Pharmacology, Biochemistry, and Behavior|June 14, 2002
Intravenous ethanol/cocaine self-administration initiates high intake of intravenous ethanol aloneAiko Ikegami, Christopher M Olsen, Sheila M Fleming, et al.
Experimental Neurology|May 18, 2004
Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenoneSheila M Fleming, Chunni Zhu, Pierre-Olivier Fernagut, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Neuroscience Letters|February 6, 2010
Mice overexpressing corticotropin-releasing factor show brain atrophy and motor dysfunctionsMiriam Goebel, Sheila M Fleming, Mulugeta Million, et al.
Molecular Therapy. Methods & Clinical Development|April 17, 2023
iPSC-derived neural precursor cells engineering <i>GBA1</i> recovers acid β-glucosidase deficiency and diminishes α-synuclein and neuropathologyYanyan Peng, Benjamin Liou, Yi Lin, et al.
Trends in Neurosciences|October 12, 2004
Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfectMichael S Levine, Carlos Cepeda, Miriam A Hickey, et al.
Molecular Neurodegeneration|December 15, 2011
Analysis of striatal transcriptome in mice overexpressing human wild-type alpha-synuclein supports synaptic dysfunction and suggests mechanisms of neuroprotection for striatal neuronsYofre Cabeza-Arvelaiz, Sheila M Fleming, Franziska Richter, et al.
The European Journal of Neuroscience|August 16, 2008
Olfactory deficits in mice overexpressing human wildtype alpha-synucleinSheila M Fleming, Nicole A Tetreault, Caitlin K Mulligan, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 22, 2004
Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synucleinSheila M Fleming, Jonathan Salcedo, Pierre-Olivier Fernagut, et al.
Neuropathology and Applied Neurobiology|March 26, 2021
Irisin treatment lowers levels of phosphorylated tau in the hippocampus of pre-symptomatic female but not male htau miceKatie A Bretland, Li Lin, Kimberly M Bretland, et al.
Behavioural Brain Research|February 7, 2018
Exacerbation of sensorimotor dysfunction in mice deficient in Atp13a2 and overexpressing human wildtype alpha-synucleinEmily R Dirr, Osunde R Ekhator, Rachel Blackwood, et al.
Pharmacology, Biochemistry, and Behavior|June 14, 2002
Intravenous ethanol/cocaine self-administration initiates high intake of intravenous ethanol aloneAiko Ikegami, Christopher M Olsen, Sheila M Fleming, et al.
Experimental Neurology|May 18, 2004
Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenoneSheila M Fleming, Chunni Zhu, Pierre-Olivier Fernagut, et al.
Pageof 6